Table 2.
Prevalence of A and AB sub-groups among the studied donors (n = 368)
| ABO phenotype | subgroup | N | % |
|---|---|---|---|
| A | A1 | 324 | 32,11 |
| A2 | 25 | 2,47 | |
| AB | A1B | 12 | 1,18 |
| A2B | 7 | 0,69 | |
| Total | 368 | 36,45 |
N-number of the studied blood donors.
Prevalence of A and AB sub-groups among the studied donors (n = 368)
| ABO phenotype | subgroup | N | % |
|---|---|---|---|
| A | A1 | 324 | 32,11 |
| A2 | 25 | 2,47 | |
| AB | A1B | 12 | 1,18 |
| A2B | 7 | 0,69 | |
| Total | 368 | 36,45 |
N-number of the studied blood donors.